Latest Insider Transactions at Hoth Therapeutics, Inc. (HOTH)
This section provides a real-time view of insider transactions for Hoth Therapeutics, Inc. (HOTH). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Hoth Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Hoth Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 16
2024
|
Robb Knie CEO and President |
BUY
Open market or private purchase
|
Direct |
25,000
+30.07%
|
$0
$0.67 P/Share
|
|
Dec 13
2022
|
Jeff Pavell Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,075
+50.0%
|
-
|
|
Sep 19
2022
|
Robb Knie CEO and President |
BUY
Open market or private purchase
|
Direct |
10,000
+1.19%
|
$0
$0.39 P/Share
|
|
Sep 16
2022
|
Robb Knie CEO and President |
BUY
Open market or private purchase
|
Direct |
10,000
+1.21%
|
$0
$0.4 P/Share
|